New York State Common Retirement Fund
NMRA icon

New York State Common Retirement Fund’s Neumora Therapeutics NMRA Stock Holding History

New York State Common Retirement Fund’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.2K Buy
+37,200
New +$70.8K ﹤0.01% 2901
2025
Q2 		– Sell
-26,025
Closed -$26K – 3289
2025
Q1 		$26K Hold
26,025
– – ﹤0.01% 2937
2024
Q4 		$276K Hold
26,025
– – ﹤0.01% 2161
2024
Q3 		$344K Sell
26,025
-8,100
-24% -$94.5K ﹤0.01% 2088
2024
Q2 		$335K Buy
34,125
+27,131
+388% +$281K ﹤0.01% 2204
2024
Q1 		$96.2K Buy
6,994
+94
+1% +$1.52K ﹤0.01% 2756
2023
Q4 		$118K Buy
+6,900
New +$84.7K ﹤0.01% 2688

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

New York State Common Retirement Fund's NMRA Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in Neumora Therapeutics (NMRA) in Q2 2026: 37,200 shares worth $63.2K. The stake represents ﹤0.01% of the portfolio and ranks #2901 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in NMRA as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in NMRA in Q4 2023 and has held it in 7 quarters since. The position peaked at $344K in Q3 2024. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

  • New York State Common Retirement Fund held 37,200 shares of Neumora Therapeutics worth $63.2K as of Q2 2026.
  • Neumora Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • Neumora Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2901 holding.
  • New York State Common Retirement Fund first reported a position in Neumora Therapeutics in Q4 2023 and has held it in 7 quarters since.
  • New York State Common Retirement Fund's Neumora Therapeutics position peaked at $344K in Q3 2024.
  • 113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.